Banker D E, Eisenman R N
Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Mol Cell Biol. 1993 Dec;13(12):7540-52. doi: 10.1128/mcb.13.12.7540-7552.1993.
Thyroid hormone receptor acts as a hormone-dependent transcriptional transactivator and as a transcriptional repressor in the absence of thyroid hormone. Specifically, thyroid hormone receptor can repress retinoic acid-induced gene expression through interactions with retinoic acid receptor. (Retinoic acid is a potent teratogen in the frog Xenopus laevis, acting at early embryonic stages to interfere with the formation of anterior structures. Endogenous retinoic acid is thought to act in normal anterior-posterior axis formation.) We have previously shown that thyroid hormone receptor RNA (alpha isotype) is expressed and polysome-associated during Xenopus embryogenesis preceding thyroid gland maturation and endogenous thyroid hormone production (D. E. Banker, J. Bigler, and R. N. Eisenman, Mol. Cell. Biol. 11:5079-5089, 1991). To determine whether thyroid hormone receptor might influence the effects of retinoic acid in early frog development, we have examined the results of ectopic thyroid hormone receptor expression on retinoic acid teratogenesis. We demonstrate that microinjections of full-length thyroid hormone receptor RNA protect injected embryos from retinoic acid teratogenesis. DNA binding is apparently essential to this protective function, as truncated thyroid hormone receptors, lacking DNA-binding domains but including hormone-binding and dimerization domains, do not protect from retinoic acid. We have shown that microinjections of these dominant-interfering thyroid hormone receptors, as well as anti-thyroid hormone receptor antibodies, increase retinoic acid teratogenesis in injected embryos, presumably by inactivating endogenous thyroid hormone receptor. This finding suggests that endogenous thyroid hormone receptors may act to limit retinoic acid sensitivity. On the other hand, after thyroid hormone treatment, ectopic thyroid hormone receptor mediates teratogenesis that is indistinguishable from the dorsoanterior deficiencies produced in retinoic acid teratogenesis. The previously characterized retinoic acid-responsive gene, Xhox.lab2, can be induced by thyroid hormone in embryos ectopically expressing thyroid hormone receptor and is less responsive to retinoic acid in such embryos. The fact that both thyroid hormone and retinoic acid can affect overlapping gene expression pathways to produce abnormal embryonic axes and can regulate the same early-expressed gene suggests a model in which thyroid hormone receptor blocks retinoic acid receptor-mediated teratogenesis by directly repressing retinoic acid-responsive genes.
甲状腺激素受体在有甲状腺激素时作为激素依赖性转录激活因子起作用,而在没有甲状腺激素时作为转录抑制因子起作用。具体而言,甲状腺激素受体可通过与视黄酸受体相互作用来抑制视黄酸诱导的基因表达。(视黄酸是非洲爪蟾中的一种强效致畸剂,在胚胎早期阶段起作用,干扰前部结构的形成。内源性视黄酸被认为在正常的前后轴形成中起作用。)我们之前已经表明,在甲状腺成熟和内源性甲状腺激素产生之前的非洲爪蟾胚胎发育过程中,甲状腺激素受体RNA(α亚型)就已表达且与多核糖体相关(D. E. 班克、J. 比格勒和R. N. 艾森曼,《分子与细胞生物学》11:5079 - 5089,1991)。为了确定甲状腺激素受体是否可能在蛙的早期发育中影响视黄酸的作用,我们研究了异位表达甲状腺激素受体对视黄酸致畸作用的影响。我们证明,显微注射全长甲状腺激素受体RNA可保护注射的胚胎免受视黄酸致畸作用。DNA结合显然对这种保护功能至关重要,因为缺少DNA结合结构域但包含激素结合和二聚化结构域的截短甲状腺激素受体不能保护胚胎免受视黄酸影响。我们已经表明,显微注射这些显性干扰性甲状腺激素受体以及抗甲状腺激素受体抗体,会增加注射胚胎中的视黄酸致畸作用,推测是通过使内源性甲状腺激素受体失活来实现的。这一发现表明内源性甲状腺激素受体可能起到限制对视黄酸敏感性的作用。另一方面,在甲状腺激素处理后,异位甲状腺激素受体介导的致畸作用与视黄酸致畸作用产生的背前部缺陷难以区分。先前鉴定的视黄酸反应基因Xhox.lab2,在异位表达甲状腺激素受体的胚胎中可被甲状腺激素诱导,且在此类胚胎中对视黄酸的反应性较低。甲状腺激素和视黄酸都能影响重叠的基因表达途径以产生异常胚胎轴并且能调节同一个早期表达基因,这一事实提示了一种模型,即甲状腺激素受体通过直接抑制视黄酸反应基因来阻断视黄酸受体介导的致畸作用。